Drugmakers increased the price of 60 products August — a sharp decline from July, which saw 110 price increases, according to a Wells Fargo drug-pricing report.
For its report, analysts at Wells Fargo reviewed PriceRx data from August.
Here are four report findings:
1. The cost of 48 drugs went down in August. In July, 32 drug prices were lowered.
2. The 60 price hikes ranged from 486 percent to 1.6 percent, with a median increase of 9.9 percent.
3. The 48 drug price decreases ranged from 1.5 percent to 88 percent, with a median decrease of 38.6 percent.
4. Seven drugs increased in price by 100 percent or more. Those drugs included: FLUoxetine, Nitrofurantoin, Irbesartan-Hydrochlorothiazide, Valsartan, Thiamine, DilTIAZem and Ondansetron. Many of these drugs are generics.